Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non-muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled Trial.
Author
Tan, W.S.
Panchal, A.
Buckley, L.
Devall, A. J.
Loubière, L. S.
Pope, A. M.
Feneley, M. R.
Cresswell, J.
Issa, R.
Mostafid, H.
Madaan, S.
Bhatt, R.
McGrath, John S
Sangar, V.
Griffiths, T. R. L.
Page, T.
Hodgson, D.
Datta, S. N.
Billingham, L. J.
Kelly, J. D.
Date
2018-09-28Journal
European urologyType
Journal ArticlePublisher
ElsevierDOI
10.1016/j.eururo.2018.09.005Rights
Archived with thanks to European urologyMetadata
Show full item recordAbstract
There is no effective intravesical second-line therapy for non-muscle-invasive bladder cancer (NMIBC) when bacillus Calmette-Guérin (BCG) fails.